Effect of Siddha medicine Sangu Parpam in the treatment of Eye disease-Blurred vision (Kan pugaichal)
Phase 2
- Conditions
- Health Condition 1: H353- Degeneration of macula and posterior pole
- Registration Number
- CTRI/2023/11/059442
- Lead Sponsor
- Dr R Devaki
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Patients diagnosed with age-related macular degeneration
Exclusion Criteria
Priror use of any prohibhited medication(s)of procedure(s) within the specified timeframe for the treatment of age-related macular degeneration
Use of anticholinergic agents within 15 days of the baseline visit
Any other condition including psychiatric illness (Depression or anxiety)
Patients diagnosed with diabetic retinopathy and cataract
End stage renal diseases and liver disorders
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method This study will discover the therapeutic effectiveness of Siddha herbo mineral formulation Sangu parpam in age-related macular DegenerationTimepoint: 48 days
- Secondary Outcome Measures
Name Time Method Reduction and improvement in th equality of life in Age-realted macular degeneration patients through Impact of Vision Impairment QuestionnarieTimepoint: 48 days